A Phase 1 Study of TT-00920 in Healthy Subjects
NCT05355129
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
TT-00920
DRUG:
TT-00920 Placebo
Sponsor
TransThera Sciences (Nanjing), Inc.